ATP-binding cassette sub-family G member 2 (ABCG2) was first named as Breast Cancer Resistance Protein in the 1990s when it was discovered in MCF-7 breast cancer cell line co-selected for doxorubicin in the presence of verapamil [9]. Here, ABCG2 is linked to breast carcinoma.